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ABSTRACT
The increasing interest in genetic manipulation of
bacterial host metabolic pathways for protein or
small molecule production has led to a need to
add new genes to a chromosome quickly and
easily without leaving behind a selectable marker.
The present report describes a vector and four-day
procedure that enable site-specific chromosomal
insertion of cloned genes in a context insulated
from external transcription, usable once in a con-
struction series. The use of rhamnose-inducible
transcription from rhaBp allows regulation of the
inserted genes independently of the commonly
used IPTG and arabinose strategies. Using lacZ
as a reporter, we first show that expression from
the rhamnose promoter is tightly regulatable,
exhibiting very low leakage of background expres-
sion compared with background, and moderate
rhamnose-induced expression compared with
IPTG-induced expression from lacp. Second, the
expression of a DNA methyltransferase was used
to show that rhamnose regulation yielded on-off
expression of this enzyme, such that a resident
high-copy plasmid was either fully sensitive or
fully resistant to isoschizomer restriction enzyme
cleavage. In both cases, growth medium manipula-
tion allows intermediate levels of expression. The
vehicle can also be adapted as an ORF-cloning
vector.
INTRODUCTION
Genetic engineering of plasmids provides a rapid and
ﬂexible method of adding individual genes to a bacterial
gene complement. However, multiple stable changes to the
metabolic architecture of a strain are often desirable,
for example providing new metabolic pathways, novel
chaperone suites to allow proper folding of exotic
target proteins, or exotic tRNA genes to allow smooth
translation of foreign codons. Strain-building strategies
thus quickly exhaust the repertoire of compatible repli-
cons and drug-selection options. Direct manipulation of
the genome itself then becomes an attractive strategy.
Genome manipulation strategies in bacteria at present
range from whole-genome synthesis (1) to selective
deletion or gene addition via homologous recombination
using PCR products (2,3) and in favorable cases oligo-
nucleotide mutagenesis in vivo (4). The ﬁrst, while a
technical tour-de-force, is not yet of routine utility. The
second is very useful, especially due to generality, but a
scar remains at the site of manipulation. The third is a
scarless method useful for making small changes, but
not for adding functions (4–6). A method less widely
used (7) requires two cloning steps, additional steps for
drug resistance removal and also leaves a scar. Older
approaches that rely on homologous recombination are
still in use but are more cumbersome (8).
Methods that focus on gene addition at deﬁned neutral
positions are useful complements to the replacement
methods. These rely on site-speciﬁc recombinase func-
tions. Lambdoid bacteriophages were the ﬁrst site-speciﬁc
systems used for adding genes to a bacterial chromosome
(9–11). The utility of the site-speciﬁc approach has been
expanded with a series of different phage integrase vectors,
but each system leaves behind a drug-resistance marker,
limiting its utility for strain building (12,13).
Transposon Tn7 has a site-speciﬁc mode of insertion,
with a unique attachment site (attTn7) downstream of the
highly conserved glmS gene. This system has the advan-
tage that it inserts at very high frequency (14) into a single
conserved site distributed through many taxa (15). A basic
mini-Tn7 (mTn7) donor plasmid vector, pGRG36, was
previously designed to deliver cargo to the speciﬁc site,
attTn7 (16). The insertion (mobilization) procedure is
straightforward: the desired DNA is placed in a multiple
cloning site located between the Tn7R and Tn7L end
sequences, at which the transposition proteins act to
move the element. The donor thus constructed has
(i) transposition genes separated from the region to be
mobilized; (ii) a selectable marker for the donor plasmid,
also separate; and (iii) a thermosensitive replicon, so that
the donor is lost from the cell when grown at 42 C. When
the donor is present in the cell at 30 C, chromosomal
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the transposition proteins. Subsequent growth at 42 C
and resulting plasmid curing allows recovery of strains
carrying these chromosomal insertions at attTn7. In the
model situation, 50–100% of colonies obtained at 42 C
carry the mobilized element inserted at attTn7. It should
be noted that the Tn7 system exhibits transposition
immunity, so that insertion of a second element into an
occupied site occurs at about a 60-fold lower frequency
than the ﬁrst insertion. With suitable transposase mutants
the frequency of second insertions is only 3-fold lower
than with wild type ﬁrst insertions (17), although the sta-
bility of such tandem elements has not been investigated.
Some complications were anticipated in the use of the
basic Tn7 donor plasmid pGRG36, stemming from
expression signals in adjacent DNA both on the donor
and in the chromosomal destination. Tn7R permits tran-
scription to enter the element from the outside; insertion
into chromosomal attTn7 disrupts the glmS transcription
terminator, allowing readthrough into the element (17).
This is an undesirable situation for the introduction of
alien genes, particularly for those encoding toxic
products. The expression context on the donor plasmid
could also be problematic for the intermediate construct:
adjacent to Tn7R is araC, reading into the element
without a terminator; adjacent to Tn7L is ori-pSC101,
with transcription also reading toward the element.
We based the design of the new vector, pMS26, on
the backbone of pGRG36, with a new cloning region
cassette between the sites of transposition protein action,
Tn7L and Tn7R. To insulate expression of cloned genes
from external signals, transcription and translation
terminators are placed immediately inside the Tn7 ends.
The design includes rhaBp, a rhamnose-regulatable
promoter; convenient cloning sites and rapid protocol;
and adaptability for use as a vector to clone open
reading frames (ORFS) stripped of their native expression
signals. ORF clones can then be expressed at the experi-
menter’s direction using tightly regulated expression
signals provided by the design for the cargo ORF. Due
to the high efﬁciency and easy cloning strategy adopted,
the present method has signiﬁcant advantages in rapidity
of construction. Performance was compared with familiar
examples in E. coli using lacZ expression with or without
its native promoter. In addition, complete plasmid protec-
tion via expression of the foreign methyltransferase,




Genetic elements and fusions are designated according to
the recommendations of ref. (18) and the American Society
for Microbiology. For brevity, ‘mini-Tn7’ is abbreviated to
‘mTn7’; it signiﬁes a genetic element mobilizable by the
Tn7 transposition proteins. Mobilization results from
action of those proteins on the two ends of the element
and moves the element with all DNA between the ends to a
new location. Each mTn7 (Table 1) is named here for the
cargo that it carries, with an allele number distinguishing
different variants of a similar construction. For example,
mTn7F(rhaBp-lacZ)1 carries a fusion of the rhamnose
promoter to the lacZ open reading frame (with one conﬁg-
uration of translation signal) while mTn7F(rhaBp-lacZ)2
carries a different such fusion (a different translation
signal). mTn7F(rhaBp-lacZp-lacZ) carries the lacZ tran-
scription unit downstream of the rhamnose promoter.
USER: Uracil Speciﬁc Excision Reagent (NEB #M5505).
USERBstBI: refers to the combination of Nt.BbvCI and
BstBI that creates long extensions for efﬁcient
USER-enabled cloning described below. These extensions
are not the same as those created by the combination of
Nt.BbvCI and XbaI described for the original
USER-enabled vector (19).
Mini-Tn7 (mTn7) elements
The elements listed in Table 1 were constructed by plasmid
digestion and ligation with high concentration ligase (for
synthetic segment received from Genscript), or processing
of PCR products obtained using primers listed in Table 2
followed by USER assembly as described below. Junction
sequences were veriﬁed for all constructions. Sequences
were assembled and analyzed using the LaserGene
suite from DNAStar. pMS26, pMS33 and pMS34 and
sequences of all plasmids and mTn7 elements are available
at Addgene (http://www.addgene.org/Elisabeth_Raleigh).
Plasmids and Synthetic DNA
pGRG36 (16) was obtained from N. Craig (Johns Hopkins
University School of Medicine). Oligonucleotides were
obtained from IDT. The T7Et-rhaBp-rrnB1t cassette was
obtained from Genscript. This cassette was cloned between
the PacI and AscI sites of pGRG36 to create pMS26.
Enzymes and size standards
All molecular biology reagents [restriction enzymes,
OneTaq Hot Start DNA polymerase, ligase (NEB202M),
Table 1. Plasmids and mTn7 donors
Vector Source mTn7 cargo Description
pMC63 NEB Not relevant Substrate for modiﬁcation by M.FnuDII (26)
pGRG36 N.Craig MCS GRG36 Tn7 delivery vector; contains tnsABCD and Tn7 left and right ends (16)
pMS26 This work MCS MS26 Multiple cloning site of pGRG36 replaced with insulated cloning and
expression cassette.
pMS33 This work F(rhaBp-lacZ)2 rhaBp-regulated lacZ ORF with short translation signal (STS)
pMS34 This work F(rhaBp-lacZ)1 rhaBp-regulated lacZ ORF with long translation signal (LTS)
pMS36 This work F(rhaBp-lacZp-lacZ) lacZ transcription unit with lacZp downstream of rhaBp
pMS37 This work F(fnuDIIM)1 rhaBp-regulated fnuDIIM ORF
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Biolabs except Pfu Turbo Cx Hotstart DNA polymerase
(Agilent Genomics).
Bacterial strains Derivatives of K-12 (NEB 10-beta and
ER2683) and B (ER2566) are listed in Table 3.
Media were Luria-Bertani [Rich Broth (RB) (20)], LB
(21) or M9 minimal salts (22). Minimal media were
supplemented with glucose or rhamnose to 0.2%, or
both glycerol and rhamnose to 0.2%. Drugs were ampi-
cillin (100mg/ml) and chloramphenicol (5mg/ml for
ER2566 derivatives, 15mg/ml for NEB 10-beta deriva-
tives). Colonies were picked with capillary pipets into
0.85% NaCl for temporary storage before colony PCR
or growth for testing of properties.
Constructions using pMS26
pMS26 was prepared for USERBstBI cloning accord-
ing to the protocol below with the following add-
itions and changes. Plasmid was puriﬁed with Qiaprep
Spin miniprep kit (Qiagen); BstBI digestion was for 6h;
the digested DNA was resuspended in 30ml1 0 m M
Tris–HCl pH 8.5. The ﬁnal concentration of linearized
DNA was about 40ng/ml. The USER assembly reac-
tion was carried out as described in Validation, below.
Step 1: USERBstBI vector preparation protocol. Complete
digestionofthesitesrevealinglongextensions isimportant.
Theprocessedvectorcanbestoredatleastforseveralmonths
at  20 C. Any standard plasmid DNA puriﬁcation can be
used as long as a phenol/chloroform extraction and subse-
quent ethanol precipitation step are employed. We have
found that Qiagen DNA column puriﬁcations may not be
completely digested unless the DNA is phenol/chloroform
extractedandethanolprecipitated.Thisprotocolisfor10mg
DNAbut can, ofcourse, be scaled up.
Protocol
1. Digest plasmid with BstBI restriction endonuclease
(NEB #R0519):





Incubate 6h to overnight at 65 C.
Table 2. Oligonucleotide primers used in this work
Primer and description Sequence
1 lacZp upstream 50-GGAGACATUCGGGCAGTGAGCGCAACG-30
2 LacZ downstream 50-GGGAAAGUGAAAAAGAATAAACCGAACATCCA-30
3 lacZ upstream (short translation signal)5 0-GGGAAAGUCACAGGAGGGACGTCATGACCATGATTACGGATTCAC-30
4 lacZ upstream with (long translation signal)5 0-GGAGACATUCATAACAATTTCACACAGGAGGGACGTCATG
ACCATGATTACGGATTCAC-30
5 fnuDIIM upstream with (long translation signal)5 0-GGAGACATUCATAACAATTTCACACAGGAGGGACGTCATG
AAAATTAAAGAAAAACGAG-30
6 fnuDIIM downstream 50-GGGAAAGUTTAATCTGTTTCTTTTTTAAAATATAG-30
7 attTn7 upstream 50-AATCTGTAACGTTCCGGGTTC-30
8 attTn7 downstream 50-CATTAATAACGAAGAGATGAC-30
Note. Primers 1–6 include upstream (50-GGAGACATU) or downstream (50-GGGAAAGU) sequences needed for subsequent USER cloning. The
30-end of primer 1 anneals 133 bp upstream of lacZ ATG; the 30-end of primer 2 anneals 80 bp downstream of lacZ stop codon TAA; primers 3 and
4 to 17 nucleotides of lacZ open reading frame beginning with ATG; primer 5 anneals to 22 nucleotides of fnuDIIM gene starting at ATG; primer 6
anneals to 26 nucleotides downstream of fnuDIIM gene ending at stop codon TAA. Translation initiation signals are italicised. Primers 7 and 8 ﬂank
the glmS terminator, into which the mini-Tn7 (mTn7) inserts.
Table 3. Strains used
Strain Genotype Source, reference
ER2566 F
- fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 R(mcr-73::miniTn10–TetS)2 [dcm]
R(zgb-210::Tn10–TetS) endA1 D(mcrC-mrr)114::IS10
NEB C2566, T7 Express
ER3019 F
- araD139 D(ara-leu)7697 fhuA lacX74 galK [80 D(lacZ)M15] mcrA galU recA1 endA1
nupG rpsL (StrR) D(mrr-hsdRMS-mcrBC)
NEB C3019, NEB 10-beta
ER2683 F’proAB lacI
q D(lacZ)M15 zzf::miniTn10 (KanR)/ fhuA2 D(lacI-lacA)200 glnV44 e14
- rfbD1?
relA1? endA1 spoT1? thi-1 D(mcrC-mrr)114::IS10
(32)
ER3169 F
- endA1 thi-1 glnV44 mcrB1 hsdR2 relA1? spoT1? rfbD1?/pBR322fnuDIIM (33)
ER3228 NEB10-beta attTn7::mTn7F(rhaBp-lacZp-lacZ)1 This work
ER3233 ER2683 attTn7::mTn7F(rhaBp-lacZ)1 This work
ER3235 ER2683 attTn7::mTn7F(rhaBp-lacZ)2 This work
ER3237 ER2566 attTn7::mTn7F(rhaBp-lacZ)1 This work
ER3238 ER2566 attTn7::mTn7F(rhaBp-lacZ)1 This work
ER3239 ER2566/pMC63 cat This work
ER3240 ER2566 attTn7::mTn7F(fnuDIIM)1/pMC63 cat This work
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(NEB #R0632) by adding 2ml (20U) of Nt.BbvCI
(10000U/ml) to the above reaction and incubating
for 1h at 37 C.
3. Purify the linearized, nicked vector by phenol–chloro-
form extraction and ethanol precipitation. Resuspend
in 30ml of Tris–HCl pH 8.5 buffer.
4. Determine vector concentration. Dilute to 20ng/ml
ﬁnal concentration Final vector concentration should
be 20–40ng/ml.
Step 2: PCR for USERBstBI cloning. Fragments (100ml
volume each PCR) to be cloned in pMS26 were prepared
using 5U Pfu Turbo Cx Hotstart DNA polymerase,
0.25mM each dNTP, and the appropriate primers listed
in Table 2 (0.5mM). Template for the PCR was either
 10ng MG1655 genomic DNA (for lacZ constructs) or
 1ng Qiagen plasmid miniprep DNA from ER3169 (for
fnuDIIM chromosomal insertions). Plasmid PCR template
was ﬁrst linearized with EcoRI to minimize plasmid
carryover during subsequent USER cloning. PCR cycling
parameters were as recommended by Agilent. Following
PCR, samples were puriﬁed using the QIAquick PCR puri-
ﬁcation kit (Qiagen) prior to the USER assembly reaction.
Steps 3–5: USER assembly, transformation and rapid
chromosomal insertion. An expedited protocol was
developed that can be used to rapidly isolate multiple in-
dependent constructs and chromosomal insertions from
them. Recovery of chromosomal insertions is lower
( 10%) with this element and protocol than the original
procedure (50–70%), but faster (4 days from PCR to
identiﬁed insertion) and more automatable.
. General materials:
 USERBstBI-compatible digested pMS26 (from step 1)
 PfuCx_TurboCx_Hotstart_DNA_polymerase
(Agilent Genomics)
 USER enzyme (NEB M5505)
 PCR puriﬁcation columns
 Universal ﬂanking primers (glmS, ptsS) to monitor
chromosomal insertion
 RB ampicillin plates
 RB no drug plates
 Incubators at 30 C and 42 C
 SOC or other outgrowth medium
. Experiment-speciﬁc materials:
 competent host cells
 DNA template




 Step 2 (described above). PCR from template (20
cycles)
 Step 3. Add USER, mix with precleaved vector
pMS26 of step 1.
 Step 4. Transform, plate on ampicillin at 30 C.
Incubate transformation plates at least 18h.
. Day 2: Step 5. Restreak 10 well-isolated colonies per
cloning without drug at 42 C; patch the same colonies
on Amp at 30 C for temporary archiving to access
plasmid later if desired. Patches should be indexed to
the streaks in some way. 1/6 plate per streak should be
enough to obtain two well-isolated colonies.
. Day 3: Patch two well-isolated colonies per Day 2
streak to storage (no drug) for temporary archiving
and test for chromosomal insertions by colony PCR,
run gel (20 per cloning). About 10% of tested colonies
will have chromosomal insertions.
. Day 4: Retrieve strains with plasmid and chromo-
somal insertions from patch plates for permanent
archiving and to test properties of chromosomal inser-
tions. This procedure can yield up to 10 independent
constructions.
Colony PCR: reactions for colony PCR screening of the
42 C colonies for chromosomal insertions contained
2.5U OneTaq Hot Start DNA polymerase (NEB) in
50ml with primers 7 and 8 (Table 2) (0.5mM each).
100ml aliquots of 0.85% saline colony suspensions were
heated to 99 C for 5min to prepare extracts; 5ml of each
extract was used for PCR. PCR cycling parameters were
as recommended by NEB.
Assays for -galactosidase were a modiﬁcation of the
Miller protocol (22). Brieﬂy, cultures were grown from
three single colonies per strain in the medium speciﬁed;
A600 was assessed directly on mid-log cultures or on a
1:5 or 1:10 dilution of late-log or stationary phase
cultures to obtain readings between 0.2 and 0.8; samples
were collected by centrifugation and resuspended in the
same volume of lysis buffer (recipe); debris was clariﬁed
by centrifugation, and 1–50ml of the extract was used in
1ml reactions with ortho-nitrophenyl-b-D-galactoside sub-
strate as described in (22). Miller units were calculated as
1000 A420/(volume time A600).
Restriction digests for determination of M.FnuDII
activity: ER3239 (negative control) and ER3240 were
tested for the ability to modify DNA in vivo using as
reporter a co-resident high-copy plasmid with an easily
diagnosed banding pattern. A total of 10ml of miniprep
DNA prepared from cells grown under various induction
regimens was digested with 3U of AclI in 1 NEBuffer
4 supplemented with 100mg/ml BSA at 37 C for 90min
to linearize the plasmid at a convenient location; 10U of
BstUI was added and incubation continued at 60 C for
one h to produce fragments diagnostic of unmodiﬁed sites.
RESULTS
pMS26 vector design
Overview. The vector pMS26 receives a desired gene
within a mobile element (Figure 1, Steps 1–3) that
inserts with high efﬁciency at a unique site in the
genome of E. coli (Figure 1, middle). The donor thus
assembled is introduced into cells by transformation
(Step 4) and selected at low temperature for ampicillin
resistance encoded by the vector. Transformants are
puriﬁed at high temperature (Step 5), leading to loss of
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ance and transposition protein genes. 10% of the sur-
vivors carry the mobile element downstream of glmS
(Figure 1, bottom), disrupting its terminator, glmSt
(Figure 2). The cloned segment is protected from expres-
sion driven by external signals with transcription and
translation terminators ﬂanking the cloning region
(Figure 3A). Inducible expression is provided by
the rhamnose-regulated promoter rhaBp (Figure 3A)
characterized by very tight control. Uninduced expression
is undetectable; maximal expression [activated by RhaS
and CRP (23)] is good, around 10% of fully induced
lacp. A cloning strategy that relies on long single-stranded
extensions (Figure 1, Step 1, USERBstBI; ‘Materials and
Methods’ section) allows this to be accomplished in four
days, without isolation of the vector intermediate to verify
its structure. The orientation of expression has been
designed to minimize potential conﬂict with adjacent
essential gene glmS (Figure 2), in case transcription
emanating from the element does not terminate com-
pletely. Restriction enzyme sites within the element
enable construction of alternative expression environ-
ments as desired (Figure 3B) while retaining protection
from external transcription and translation.
Rationale and uses of the cloning region. A preliminary
trial using pGRG36 revealed problems with transcription
entering the mobile element from vector or chromosome
(data not shown). Transcription from glmS on the
chromosome and from araC on the vector will read into
the element from the right (Figure 2 showing the E. coli
chromosomal region; vector not shown). Transcription
from repA on the vector will read in from the left (not
shown); but ptsS reads away on the chromosome
(Figure 2). Accordingly, design of pMS26 provides insu-
lation from outside promoters and from translational
readthrough both in the plasmid vector and in the
chromosomal location. This is accomplished with
three-frame stop codons inside each border, and transcrip-
tion terminators (rrnBt inside Tn7R, the T7 early termin-
ator T7Et inside Tn7L) as displayed in Figure 3A.
The T7Et terminator is NOT adapted to terminate
T7 RNAP; rather it functions in termination of early tran-
scripts read by the E. coli RNAP (24). Here, it is oriented
to terminate incoming transcription. The rrnBt terminator
is reported to act bidirectionally (25). Providing regulated
Figure 1. pMS26 mediates efﬁcient insertion of a gene into a unique
chromosomal location. The squiggly black line is pMS26 backbone,
encoding transposition proteins, thermosensitive replication and ampi-
cillin resistance. The mobile element mTn7(MCS MS26) is indicated by
ﬁlled yellow and green arrows (Tn7 ends required for transposition
protein to act) ﬂanking the the cloning region (black box). The
desired cargo (Your Favorite Gene, YFG) is represented by the blue
arrow. Ovals represent bacterial cells; circles are chromosomes. The
dashed yellow line represents the action of transposition proteins at
the mobile element ends (Tn7R and Tn7L) and at the unique attach-
ment site (red square on the chromosome). Action results in insertion
of the element into the chromosome downstream of of glmS. pMS26
(and the assembled donor carrying YFG) can’t replicate at 42 C. All
survivors of 42 C growth have lost the donor; 10% have gained an
insertion of mTn7(YFG). Numbers are steps of the strain construction
process, described in the text.
Figure 2. Gene organization surrounding mTn7(MCS MS26) in the chromosomal site. For legibility, the ‘empty’ transposon mTn7(MCS MS26)
with no gene cloned is shown inserted in the chromosomal attTn7. The double bar shows distance (bp) from the end of pstS. Green arrows are genes
(oriented with translation) coding for PstS (component of phosphate ABC transporter) and GlmS (glucosamine-6 phosphate synthase, essential for
cell wall synthesis). Yellow and ochre arrows are the imperfect inverted repeats at which Tn7 transposition proteins act. Tn7L and Tn7R are not
identical, and insertion is always in the orientation shown. Brown box is the multiple cloning site of pMS26; black boxes outlined in red are
terminators: the glmS transcription terminator is interrupted by the insertion (as shown with apostrophe; glmSt’, ‘glmSt); transcription terminators
(rrnBt, T7Et) insulate the MCS in mTn7(MCS MS26) from readthrough of external transcription.
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goal; the sequence of the rhaB regulatory region was
designed based on reference (23) and corresponds to
bases  289 to  99 relative to the transcription start of
rhaBAD in Fig. 1 of that reference. Use of cloning and
expression options provided is discussed further below.
USER-facilitated cloning protocol. Efﬁcient USER-
facilitated cloning can be used to clone downstream of
rhaBp. See ‘Materials and Methods’ section for a descrip-
tion of how to process the vector for this purpose (Step 1.
USERBstBI Vector Preparation).
(1) Design of USER-facilitated cloning for rhaBp expres-
sion and evaluation.
Cloning with 8–12 basepair single-stranded extensions
substantially improves the efﬁcient recovery of inserts
(19). Long single-strand extensions on insert DNA frag-
ments can be created by employing uracil-containing PCR
primers, followed by excision of uracil, and cleavage at the
abasic site thus created. The excision and cleavage reac-
tions are accomplished with the USER enzyme mixture
(19). In the original report,  95% of transformants
contain the designed clone; this efﬁciency has been
reproduced here.
USERBstBI extensions: Creation of long extensions on
the vector requires use of suitably disposed sites for a type
II restriction enzyme and a nicking enzyme; in the original
conﬁguration, this was achieved with XbaI and
Nt.BbvCI, each of which must be unique in the cloning
vector. In the present instance, the starting vector
pGRG36 had no BbvCI sites, but numerous XbaI sites
were present. The type II enzyme must have a T 50 to its
cleavage position for the strategy to work; we identiﬁed
BstBI (TTjCGAA) as a substitute for XbaI (TjCTAGA)
that would be unique in the vector. For convenience, we
call the resulting extensions USERBstBI extensions.
Since BstBI cleaves after the second base of its site
instead of after the ﬁrst, use of this enzyme for vector
preparation instead of XbaI necessitates adding an extra
T before the target U to the PCR primer when amplify-
ing the desired insert (see below).
(2) Design of primer for USER cloning with pMS26.
To use this vector processed as described in ‘Materials
and Methods’ section, design PCR primers for your
Figure 3. Components of mTn7(MCS MS26).( A) Functional components of the transposon. Orientation has been reversed from that shown in
Figure 2 to more easily envision expression. Distance from the end of Tn7R is shown (basepairs) below the double bar. Filled arrows: the ends of
Tn7, at which the transposition proteins act to mobilize the element. The ends differ, so that the element always inserts with Tn7R (shown on the left
here) adjacent to glmS (Figure 2). Boxes: insulating elements and cloning region–orange, three-frame translation stops (reading in); black/red,
transcription terminators (reading in); yellow, multiple cloning site. Capped black bar shows the extent of the rhaB regulatory region. Below this
are shown the regulatory sites involved: green arrow, promoter; pink bars, binding sites for the transcription activators RhaS and CRP. RhaS
activates in the presence of rhamnose; CRP further activates in the absence of glucose (23). (B) Cloning options. Cloning sites discussed in the text
are indicated above the double bar; distance from the outside end of Tn7R is marked below it. Alternative segments discussed in the text are shown
with capped lines: ‘rhaB regulatory region’ is the same as that shown in Figure 3A; ‘USER clone replaces’ indicates the segment replaced during
USER cloning as described in the text; ‘Substitute promoter replaces’—a desired substitute promoter may cloned between XhoI and PacI. Black
arrow: ‘TLsig’ provides 50-UTR translation initiation signals for substitute promoters, directing translation of ORFs cloned at the AatII site.
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that these primers cannot be used with pNEB206A due to
the extra base.)




Downstream reverse complement (C-terminal side):
50GGGAAAGTU-your-downstream-primer-binding-
site30
Transcription unit cloning: If the goal of the experiment
is to use the native promoter and regulatory sites for
expression, the primer binding sites should be upstream
of that transcription unit. UserBstBI cloning will
result in rhaBp upstream in tandem with the native
promoter. In the absence of rhamnose, rhaBp is essentially
silent.
Translation unit cloning:I frhaBp-directed expression is
desired, the primer-binding sites should be upstream of
translation signals (essentially the 50 untranslated region
or 50-UTR) for your gene, or else translation signals
should be designed into the primers. Two options for
translation signals are described in the results below and
displayed in Figure 4.
(3) Insert preparation, USER assembly and transformation
Efﬁcient insertion results from PCR with primers
described above and in Figure 4. These contain strategic-
ally located uracil, which can be acted on by the USER
reagent to reveal 30 single-strand extensions compatible
with the processed vector (step 3 in Figure 1). For
complex assemblies of multiple fragments, ligation and
gel puriﬁcation is recommended (19). However, if a
single amplicon contains all the genes of interest,
ligation is not needed and the assembly mixture can be
transformed directly, plated on ampicillin and incubated
at low temperature to allow vector replication. Expression
of transposition proteins during colony growth results in
mobilization of the mTn7 to its chromosomal target,
attTn7 (Figure 1, middle). Repuriﬁcation of transformant
colonies at 42 C in the absence of ampicillin (Step 5 of
Figure 1) results in efﬁcient plasmid loss. The survivors all
lack the plasmid, and about 10% carry mTn7 inserted at
attTn7.
Restriction enzyme cloning options. Alternatives to the
USER cloning protocol and rhaBp expression are also
enabled in pMS26. At least three expression conﬁgur-
ations can be achieved using restriction enzyme sites in
the vectors described here:
(1) Transcription unit cloning. For cloning of a gene or
operon with its own expression signals, standard re-
striction enzyme cloning can be carried out between
PacI on one side and AscI, NotI, PmeI, BbvCI,
BstBI, AatII (ZraI) or XhoI (PspXI) on the other
(Figure 3B). PacI, AscI, NotI and PmeI recognize
8bp sites, and BbvCI recognizes 7 bp; thus, the like-
lihood of interfering sites occurring in the cloned
fragment is much lower than if using common
6-base sites. Using this approach, no promoter or
translation signals are provided; thus, expression
must be directed by the insert. Transcription unit
cloning can also employ the USERBstBI-facilitated
procedure (see above).
(2) Creating an ORF-expression vehicle with a different
promoter. The expression region is set up to allow
replacement of rhaBp with an alternative promoter
and provides translation signals for this (Figure 3A
and B). To replace rhaBp and convert to a consti-
tutive ORF-cloning vector, digest with XhoI and
PacI to remove the rhaBp regulatory region and
insert an oligonucleotide or fragment specifying a
constitutive promoter such that transcription is
directed to begin at or before the translation signal
(50-UTR) region (‘TL sig’). (This signal is the same
as ‘LTS’ described above and evaluated below in the
context of rhaBp expression validation.) This will
create a vector that can subsequently be used for
ORF cloning: insert the ORF of interest at the
AatII site, with an ATG immediately following the
AatII site.
(3) Rhamnose-regulated expression vector. Standard
restriction enzyme cloning for example between the
two BbvCI sites, between the two BstBI sites, or
between one of these and the AscI, NotI or PmeI
sites will allow use of rhaBp (a rhamnose-activated
promoter) as an inducible promoter (Figure 3).
Translation signals should be designed into the
insert to use this option.
Alternatively, plasmids that already have translation
signals (described below, pMS33 or pMS34) can be
adapted as ORF-cloning vectors with lac stuffer
fragment, allowing rhaBp-directed expression. The lacZ
fragment can be replaced with an alternative by digesting
with AatII at the N-terminal end of the coding sequence
and PmeI, NotI or AscI at the C-terminal end. Blue-white
Figure 4. Design of primers for USER cloning with pMS26. Two
choices of translation signal in the 50-UTR are shown. The gene-speciﬁc
sequence illustrated is of fnuDIIM. The underlined 21 bp of longer
translation signal (LTS) is from the tacp regulatory region (34); the
short signal (STS) is a truncation of it. The LTS and downstream
primers illustrated are the same as primers 5 and 6 of Table 4; the
STS construct was made but not used in this report. Fusion of lacZ
to the signal as shown creates an RBS/ATG spacing of six, within the
usual range of spacing (35); lacZ native spacing is seven (36).
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identify replacement clones.
Method Validation
Validation of cloning protocol. In constructing ER3228
containing mTn7F(rhaBp-lacZp-lacZ)1, 0.06 pmole
PCR product obtained using primers 1 and 2 of Table 2
(10ml of 0.006ng/ml) and 0.005pmole (1ml, 40ng) pro-
cessed pMS26 were incubated with 1 unit of USER
enzyme in a total volume of 12ml for 15min at 37 C,
and then incubated 15min at room temperature. 3mlo f
the assembly reaction (10ng of pMS26) was mixed imme-
diately with 50ml commercial competent ER3019 host
cells, incubated on ice for 30min, at 37 C for 2min, and
ﬁnally on ice for 5min. Cells were gently mixed with 1ml
LB and outgrown at 30 C for 1h. 100ml of undiluted,
10-fold diluted and 100-fold diluted culture was plated
on LB with 100mg/ml ampicillin and incubated 24h at
30 C. 7300 transformants/ml were obtained (7 10
5
permg processed vector). When the transformation mix
was replated at 30 C with IPTG-Xgal present,  3/5000
colonies were white, indicating a very low frequency of
vector without insert.
With lesser insert-vector ratios and cells of lower com-
petence, 20–200 colonies typically resulted from plating




Validation of chromosome insertion protocol. Table 4
shows ﬁve trials in two strains employing the rapid inser-
tion protocol. On the day following transformation of
each USER assembly reaction, 7–20 transformants were
streaked on to LB plates without drug and incubated over-
night at 42 C to cure the plasmid.
Colonies picked from the 42 C plates were analyzed by
colony PCR. Primers 7 and 8 (Table 2) yielded a product
of 841 bp for an empty attTn7 site, while colonies with
lacZ or fnuDIIM inserts display products of 5129 and
3201 bp, respectively. The observed ratio # inserts/#
tested colonies are given in Table 4, lines 1–5. Trials
with two conﬁgurations of lacZ and one of fnuDIIM as
cargo using the pMS26 vector in two hosts consistently
yielded an insertion frequency of  10% (Table 4).
We considered the possibility that additional gener-
ations of growth in the presence of the donor, or simply
longer time, might yield a higher frequency of chromo-
somal insertion. To test this, in one experiment trans-
formants ( 10
7cells/colony) were patched onto LB
Amp, incubated overnight at 30 C, then a plug ( 10
7
cells/plug) from the patch was grown in 1ml RB at 30 C
overnight ( 10
9total cells) then diluted and plated at 42 C
overnight to cure the plasmid. This longer protocol had no
effect on the fraction of descendants with insertions (Line
6 of Table 4).
Validation of expression parameters using the gene for
-galactosidase, lacZ.
(1) A transplanted lac promoter displays expected IPTG
induction.
When the entire lacZ expression region is included in
the cloned fragment, an appropriate 100-fold IPTG-
dependent induction ratio is seen (compare lines 4 and 6
of Table 5). Rhamnose addition did not signiﬁcantly
increase b-galactosidase expression above the background
from uninduced lacp (compare line 4, Table 5 with line 5,
Table 5), suggesting that LacI binding may block RNAP
transcription from rhaBp in this conﬁguration. The
nearest LacI binding site is 31bp from the rhaBp tran-
scription initiation site. The background (level in the
absence of any element, 100–200U, lines 1–3) is indistin-
guishable from zero; note that the detection limit can be
reduced by using more cells and longer incubation times
(increasing the denominator in calculating Miller units).
(2) Maximal rhaBp expression and translation signal
comparison.
Expression of b-galactosidase in the mTn7(MCS
MS26) context was evaluated in two experiments using
rhaBp, USER cloning and the two different 50-UTRs
illustrated in Figure 4, with results shown in Figure 5.
The longer version [mTn7F(rhaBp-lacZ)1; LTS] of the
50-UTR consistently yielded 2- to 3-fold more activity
than the short version [mTn7F(rhaBp-lacZ)2; STS].
Expression driven by rhaBp in this context (in minimal





1 ER2683 mTn7F(rhaBp-lacZ)1 1/10 ER3233
2 ER2683 mTn7F(rhaBp-lacZ)1 1/7 NA
3 ER2683 mTn7F(rhaBp-lacZ)2 1/10 ER3235
4 ER2566 mTn7F(rhaBp-lacZ)1 2/10 ER3237,
ER3238
5 ER2566 mTn7F(fnuDIIM)1 3/20
6 ER2683 mTn7F(rhaBp-lacZ)1 1/10 NA
Note. The rapid chromosomal insertion protocol was used except in
trial 6, for which a longer protocol was used as described in the text.
Donor plasmids pMS33 [mTn7F(rhaBp-lacZ)2] and pMS34
[mTn7F(rhaBp-lacZ)1] resulted from trials 2 and 4 (see Table 1) and
were recovered from patches saved at low temperature as described in
‘Materials and Methods’ section, constructions with pMS26, Day 2.
Insertion was veriﬁed with PCR primers 7 and 8 of Table 2. Trials 1
and 2 were carried out on different days with different PCR reactions.
Table 5. IPTG-inducible lacZ expression from lacp
Element Medium Avg MU StDev
1 None RB 175 87
2 None RB Rha 127 98
3 None RB IPTG 225 279
4 mTn7F(rhaBp-lacZp-lacZ)1 RB 3274 976
5 mTn7F(rhaBp-lacZp-lacZ)1 RB Rha 4168 590
6 mTn7F(rhaBp-lacZp-lacZ)1 RB IPTG 312726 76343
Note. Data averaged from two experiments on different days. Miller
units (MU) were determined as described in ‘Materials and Methods’
section, with 1ml of overnight culture and assay time of 7–45min.
Strains used were ER3019 and ER3228. SD is standard deviation of
the two triplicate determinations.
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induced lacZ (in RB; compare with Table 5).
(3) 1000-fold rhamnose induction of rhaBp.
Choice of growth media allows modulation of expres-
sion by rhamnose over a 1000-fold range, from the
combined effect of catabolite activation and rhamnose
activation. Table 6 shows that uninduced and glucose-
repressed expression using STS (lines 7–9) is indistinguish-
able from the background with no lacZ (lines 1–3), while
LTS may be slightly higher (line 4–6). Rhamnose re-
sults (lines 10–15) are the same data as experiment 2 of
Figure 4, showing improved expression mediated by the
LTS. Growth supported by glycerol together with
rhamnose yields somewhat lower speciﬁc activity than
rhamnose alone (line 16–18 of Table 6; Miller units are
normalized for A600, a proxy for protein content). This
mixture of carbon sources both subject to catabolite acti-
vation, in which both the rhamnose and glycerol regulons
are sharing the positive activator CRP, may lead to lower
expression of each regulon due to competition for activa-
tor. Despite the lower speciﬁc activity, the growth
properties of all tested strains are considerably better
when glycerol is present with or without rhamnose
(shorter lag, faster growth and higher density; growth
curves not shown).
Validation of rhaBp expression using a methyltransferase
gene, fnuDIIM. Regulated expression is not limited to
the reporter lacZ that was used for literature comparison.
A strain constructed to drive expression of the FnuDII
DNA methyltransferase from the rhaB promoter also
showed large sugar-dependent expression changes. The
substrate pMC63 is a high-copy plasmid with two
CGCG sites, which can be modiﬁed by M.FnuDII or
cleaved by BstUI (26). Plasmid-encoded CGCG sites
modiﬁed by the methyltransferase (during cellular propa-
gation in this experiment) are protected from BstUI
cleavage (27). Figure 6 illustrates the protective action
in vivo, mediated by induction of the methyltransferase
in ER3240, containing pMC63 as a reporter and
mTn7-F(fnuDIIM)1 as an expression construct. When
this plasmid was grown in the presence of fnuDIIM in
M9 rhamnose, the in vivo expression levels were sufﬁcient
to fully modify these CGCG sites [no cleavage of the
AclI-linearized extracted plasmid, lanes (minimal, R,+)].
On the other hand, the in vivo expression levels only par-
tially modiﬁed the CGCG sites within pMC63 when
grown in rich medium with rhamnose (rich, R, +).
Glucose-grown cultures did not protect at all (minimal,
G, +; rich G, +): the digest patterns match those from
cultures entirely lacking the mTn7F(fnuDIIM)1 element
(minimal, G,  ; minimal, R,  ; rich, G,  , rich, R,  ).
DISCUSSION
The complex transposon Tn7 has several features that can
be adapted for genetic tool development. In the present
study, the high-speciﬁcity, high-efﬁciency pathway target-
ing attTn7 is the aspect of interest. This pathway, directed
by the target selector protein TnsD together with the

















































Figure 5. Rhamnose-driven expression with two translation initiation
signals. Two experiments measured b-galactosidase expression driven
by rhaBp and two variant translation signals (MU, a measure of
speciﬁc activity). Cultures of ER3233 [LTS; mTn7F(rhaBp-lacZ)1]
and ER3235 [STS; mTn7F(rhaBp-lacZ)2] were grown in M9 with
0.2% rhamnose; ER2683 (no element) was grown with 0.2% glucose.
Volume of extract used was 1 or 50ml of undiluted culture; time of
incubation was 15–128min. Using this approach, the empty site back-
ground was 5.4 MU. Average and standard deviation of three replicate
cultures is shown.
Table 6. Effect of carbon source
C-source Element MU Mean MU Induction
1 Glu None-1 4 5
2 Glu None-2 1
3 Glu None-3 11
4 Glu LTS-1 17 18 (1)
5 Glu LTS-2 7
6 Glu LTS-3 29
7 Glu STS-1 8 5 (1)
8 Glu STS-2 5
9 Glu STS-3 1
10 Rha LTS-1 27912 28993 1639
11 Rha LTS-2 30912
12 Rha LTS-3 28155
13 Rha STS-1 7126 8527 1764
14 Rha STS-2 7194
15 Rha STS-3 11261
16 GlyRha LTS-1 13671 18167 1027
17 GlyRha LTS-2 15112
18 GlyRha LTS-3 25717
Note. Effect of carbon source.
Triplicate colonies of ER2683 (no element), ER3233 (LTS) and ER3235
(STS) were suspended in 300ml saline, and 100ml each was inoculated
into 2ml M9 with glucose (Glu) or rhamnose (Rha) at 0.2% or with
rhamnose and glycerol (GlyRha) at 0.2% each as carbon source, grown
to saturation, and then assayed as in Figure 5. Each culture is reported
separately; mean MU is the average of the triplicate cultures;‘induction’
is the ratio of mean MU, for each element and carbon source, to the
glucose result for that element. Cultures with the same number in the
‘element’ column originated from the same colony.
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number (Burkholderia) of sites in a broad array of
bacteria (28). Even human DNA has a high-efﬁciency
site, also near a gene encoding N-acetyl glucosamine
synthase (29). This highly conserved gene (glmS in
bacteria) provides the widely distributed recognition site,
but since the site of actual insertion is outside the coding
region, downstream of the recognition site, insertion is
well-tolerated.
The arrangement presented here mitigates some of the
problems associated with using the original pGRG36
system. Genes within the mobile element are insulated
from expression signals originating outside of it, and the
high-efﬁciency cloning approach reduces problems
associated with manipulation of large plasmids.
High efﬁciency insertion allows screening (examination
one-by-one) rather than selection (using drug selection to
eliminate unproductive background) for the construct
desired. The mobile element mTn7(MCS MS26), carried
on pMS26, still retains an insertion efﬁciency high enough
to allow screening rather than selection for chromosomal
insertions (10% of 42 C survivors; Table 4). Although
ampicillin is used to select for the presence of the ini-
tial construct, that construct is efﬁciently lost at 42 C,
and drug-sensitivity is restored in the ﬁnal strain. The
streamlined insertion protocol was effective in two host
strains of very different pedigrees, with three constructs
of distinct function. Possibly the insertion efﬁciency
might be further increased by adding arabinose to the
ampicillin plates used to select transformants (Step 4 of
Figure 1).
The mobile element mTn7(MCS MS26) presumably
could also be mobilized via the TnsE-dependent random
insertion pathway that targets conjugal plasmids. We have
not tested this lower efﬁciency transposition pathway.
TnsE is not encoded on pMS26 but could be provided
in trans.
We compared the rhaBp expression system to the
well-characterized lac expression system in several ways.
One trial (Table 5) examined lacI-regulated expression of
the lacZ transcription unit, in the context of the
mTn7(MCS MS26) element. In this situation lacZp
directed transcription and was regulated by LacI
encoded on the 80 D(lacZ)M15 prophage resident in
the host. The mTn7F(rhaBp-lacZp-lacZ)1 element
contains, downstream of rhaBp, a segment of wild-type
lac operon sequence extending from the end of lacI to
the beginning of lacY, including all annotated regulatory
elements. In the absence of rhamnose, IPTG mediates a
100-fold induction, similar to induction seen in the
wild-type lac operon (not counting glucose repression,
not measured here) and in other lacZ reporter controls
[see, e.g. (30); lacUV5p was examined in that case].
Also notable was the lack of rhamnose induction above
the background expression from uninduced lacp. The
rhaBp transcription start is 31 bp from the closest
(furthest upstream of lacp) LacI binding site. Several
mechanisms by which bound regulators could interfere
with each other or with RNAP can be imagined.
The provision of a tightly controlled inducible rhaBp
promoter together with a strong translation initiation
region adds ﬂexibility. Expression is very low in the
presence of glucose [Table 6, lines 4–9 and Figure 6
lanes (G,+)], indistinguishable from the negative control
(Table 6, lines 1–3; Figure 6, lanes (G, –; R, –)]. The
highest expression was achieved by combining the strong
translation signal (LTS) in M9 medium with rhamnose as
sole carbon source (Table 6, lines 10–12; Figure 5, LTS;
Figure 6, M9, R,+). The level of -galactosidase activity
was  10% of fully induced lacZ from its own promoter
(compare Table 5, IPTG with Table 6, lines 10–12).
For reasons we have not explored, growth under these
conditions is slow, and ﬁnal cell yields are half that with
glucose as carbon source. Induction of the rhamnose
operon is known to be slow (31), possibly accounting for
the long growth lag.
Intermediate expression levels can be achieved by com-
bining rhamnose with other nutrients (M9 glycerol+
rhamnose, Table 6, lines 16–18; rich+rhamnose,
Figure 6, lanes rich, R,+).
Figure 6. Complete in vivo modiﬁcation of pMC63 by rhaBp-driven
fnuDIIM.( A) Methylated (protected, uncut) substrate (U) and
products (a–d) expected from digestion of AclI-linearized pMC63
with BstUI. The BstUI sites (CGCG; arrows) will be protected from
digestion when modiﬁed by M.FnuDII (CGCG ! mCGCG).
Fragments (b) and (d) are expected from a complete digest; fragments
(a) and (c) may be expected in partial digests, as may occur when the
plasmid is partially modiﬁed. A 63-bp central fragment is also expected
from complete digestion but runs off the gel in (B). (B) pMC63 was
prepared from cultures of ER3239 (M gene  ) or ER3240 (M gene+).
Cultures were grown in M9 (minimal, duplicates grown) or RB (rich,
triplicates grown) supplemented with 0.2% sugar: glucose (G) or
rhamnose (R) to repress or induce expression of fnuDIIM. The extent
of in vivo modiﬁcation was tested by BstUI digestion of AclI-linearized
plasmid DNA prepared from the cultures and interpreted according to
the diagram in panel A. Size standards on each side are the 2-log ladder
(L); selected bands are labeled with size in kb. The gel system was 1%
agarose with Tris–borate buffer containing ethidium bromide. Higher
cell density in RB accounts for higher yields in plasmid preps. The
low-intensity band at the position of ‘U’ in the rich broth cultures
G ,R   and G+ (which all should be unmodiﬁed at BstUI sites) pre-
sumably are linears that result from BstUI cleavage of plasmid that
escaped AclI digestion.
e19 Nucleic Acids Research, 2012,Vol. 40,No. 3 PAGE 10 OF 12The donor plasmid pMS26 also was designed to accom-
modate alternative cloning and expression strategies, as
described in the section on vector design. Such modiﬁed
protocols will still enjoy the insulation from external
expression and the high insertion speciﬁcity of the
mobile element described here.
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